DCGI gives nod to Cadila Healthcare to conduct phase-III trials for two-dose COVID vaccine
The company has already received the Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
DCGI gives nod to phase-I clinical trial of COVID-19 vaccine by Reliance Life Sciences
The trials will be conducted at eight sites in Maharashtra
Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DG
Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adjunct…
DCGI gives nod for Biological E’s COVID-19 vaccine’s phase-II/III trials on kids aged…
The trial will be conducted across 10 sites in the country
J&J seeks Indian regulator’s nod for COVID vaccine trials on adolescents
Earlier this month, the government had given Emergency Use approval to J&J’s single-dose COVID vaccine in India
Zydus Cadila’s COVID vaccine ZyCoV-D gets approval for Emergency Use Authorisation
With EUA, ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country
Cadila Healthcare’s net profit rises 29 per cent in Q1
Consolidated total revenue from operations stood at Rs 4,025.4 crores for the quarter under consideration against Rs 3,514.6…
J&J committed to bring its COVID jab to India after withdrawing proposal
"Since the Drugs Controller General of India (DCGI) recently directed that there is no longer a requirement to conduct bridging…
Working with Moderna to see make its COVID vaccine available in India: Govt
Moderna's COVID-19 vaccine was granted emergency use authorisation last month
Mankind Pharma gets DRDO nod to make and market 2-DG
The company will manufacture the product at its facilities in Visakhapatnam and Himachal Pradesh